All terms in EFO
| Label | Id | Description |
|---|---|---|
| obsolete_amyotrophic lateral sclerosis type 4 | Orphanet_357043 | |
| Hippuric Acid | NCIT_C87277 | |
| obsolete_intellectual disability-facial dysmorphism-hand anomalies syndrome | Orphanet_370010 | |
| obsolete_spondyloepimetaphyseal dysplasia, Isidor type | Orphanet_370015 | |
| Agrobacterium tumefaciens str. C58 | NCBITaxon_176299 | |
| losartan | CHEBI_6541 | [A biphenylyltetrazole that has formula C22H23ClN6O., A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position, A monounsaturated very long-chain fatty acid with a 22-carbon backbone and a single double bond originating from the 9th position from the methyl end, with the double bond in the trans- configuration.] |
| obsolete_autosomal recessive cutis laxa type 2B | Orphanet_357064 | |
| obsolete_autosomal recessive cutis laxa type 2A | Orphanet_357058 | |
| obsolete_spondylometaphyseal dysplasia, Czarny-Ratajczak type | Orphanet_370019 | |
| Populus euphratica | NCBITaxon_75702 | |
| Congenital pulmonary alveolar proteinosis | Orphanet_264675 | [Congenital pulmonary alveolar proteinosis is a very rare primary interstitial lung disease due to pulmonary surfactant accumulation within the alveolar macrophages and alveoli, characterized by a variable clinical course ranging from an asymptomatic clinical presentation and spontaneous remission, to symptoms such as dyspnea and cough, or to severe respiratory failure.] |
| ND00051 | CLO_0029732 | [POPULATION/CONVENIENCE CONTROL] |
| obsolete_partial deletion of the long arm of chromosome 2 | Orphanet_262010 | |
| Lagos bat virus | NCBITaxon_38766 | |
| Duvenhage virus | NCBITaxon_38767 | |
| Nicotiana langsdorffii x Nicotiana sanderae | NCBITaxon_164110 | |
| Southern bean mosaic virus | NCBITaxon_12139 | |
| obsolete_partial deletion of the long arm of chromosome 3 | Orphanet_262019 | |
| response to aspirin | GO_1903492 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an acetylsalicylate stimulus." [GO_REF:0000071, GOC:TermGenie, PMID:23392654]] |
| response to simvastatin | GO_1903491 | ["Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a simvastatin stimulus." [GO_REF:0000071, GOC:TermGenie, PMID:23100282] comment: Simvastatin is a statin used as a cholesterol-lowering and anti-cardiovascular disease drug.] |